Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-Interventional, Multicenter, Multicohort Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Subcutaneous Atezolizumab in Participants Treated in Routine Clinical Practice

NCT07284121 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT07284121
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07284121 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-Interventional, Multicenter, Multicohort Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Subcutaneous Atezolizumab in Participants Treated in Routine Clinical Practice
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Recruiting
Start date
July 15, 2025
Completion date
December 31, 2028
Enrollment
700 (estimated)
Sites
92

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, hepatocellular carcinoma